Atlas Trials

Bevacizumab With Pelvic Radiotherapy And Primary Chemotherapy in Patients With Poor-Risk Rectal Cancer

Clinical trial NCT01481545 · COMPLETED

Trial details

NCT number
NCT01481545
Sponsor
National Cancer Institute, Naples
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Rectal Cancer
Start date
2006-12-01
Primary completion
2011-07-01
Enrollment
62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.